Biao H.
Founder and CEO

Blue Lake Biotechnology is developing a human vaccine that employs a novel viral vector to generate a strong immune response against infectious diseases. This technology aims to improve vaccine efficacy and increase accessibility in response to the global demand for effective immunization solutions.
Raised to date
$18.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founder and CEO